Re: Hiury S. Andrade, Homayoun Zargar, Peter A. Caputo, et al. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma. Eur Urol 2016;69:1149-54

Affiliations

¹ Department of Urology, Chuncheon Sacred Hospital, Hallym University College of Medicine, Chuncheon, Republic of Korea.
² Department of Urology, Tanta University Hospital, El Gharbeya, Egypt; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
³ Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: khrha@yuhs.ac.

Comment

Tae Young Shin et al. Eur Urol. 2016 Oct.

. 2016 Oct;70(4):e100-e101.

doi: 10.1016/j.eururo.2016.02.066. Epub 2016 Mar 16.

¹ Department of Urology, Chuncheon Sacred Hospital, Hallym University College of Medicine, Chuncheon, Republic of Korea.
² Department of Urology, Tanta University Hospital, El Gharbeya, Egypt; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
³ Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: khrha@yuhs.ac.

No abstract available

Comment on

Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
Andrade HS, Zargar H, Caputo PA, Akca O, Kara O, Ramirez D, Haber GP, Stein RJ, Kaouk JH. Andrade HS, et al. Eur Urol. 2016 Jun;69(6):1149-54. doi: 10.1016/j.eururo.2015.12.004. Epub 2015 Dec 22. Eur Urol. 2016. PMID: 26719014